Nilsson FY - Search Results

1

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

Steffen AC, Orlova A, Wikman M, Nilsson FY, Ståhl S, Adams GP, Tolmachev V, Carlsson J. Steffen AC, et al. Among authors: nilsson fy. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):631-8. doi: 10.1007/s00259-005-0012-3. Epub 2006 Mar 15. Eur J Nucl Med Mol Imaging. 2006. PMID: 16538504

2

In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.

Nordberg E, Orlova A, Friedman M, Tolmachev V, Ståhl S, Nilsson FY, Glimelius B, Carlsson J. Nordberg E, et al. Among authors: nilsson fy. Oncol Rep. 2008 Apr;19(4):853-7. doi: 10.3892/or.19.4.853. Oncol Rep. 2008. PMID: 18357367

3

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Ståhl S, Carlsson J. Steffen AC, et al. Among authors: nilsson fy. Cancer Biother Radiopharm. 2005 Jun;20(3):239-48. doi: 10.1089/cbr.2005.20.239. Cancer Biother Radiopharm. 2005. PMID: 15989469

4

Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.

Orlova A, Nilsson FY, Wikman M, Widström C, Ståhl S, Carlsson J, Tolmachev V. Orlova A, et al. Among authors: nilsson fy. J Nucl Med. 2006 Mar;47(3):512-9. J Nucl Med. 2006. PMID: 16513621 Free article.

5

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Tolmachev V, Nilsson FY, Widström C, Andersson K, Rosik D, Gedda L, Wennborg A, Orlova A. Tolmachev V, et al. Among authors: nilsson fy. J Nucl Med. 2006 May;47(5):846-53. J Nucl Med. 2006. PMID: 16644755 Free article.

6

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.

Tolmachev V, Orlova A, Nilsson FY, Feldwisch J, Wennborg A, Abrahmsén L. Tolmachev V, et al. Among authors: nilsson fy. Expert Opin Biol Ther. 2007 Apr;7(4):555-68. doi: 10.1517/14712598.7.4.555. Expert Opin Biol Ther. 2007. PMID: 17373906 Review.

7

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

Nordberg E, Friedman M, Göstring L, Adams GP, Brismar H, Nilsson FY, Ståhl S, Glimelius B, Carlsson J. Nordberg E, et al. Among authors: nilsson fy. Nucl Med Biol. 2007 Aug;34(6):609-18. doi: 10.1016/j.nucmedbio.2007.05.010. Nucl Med Biol. 2007. PMID: 17707800

8

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.

Friedman M, Orlova A, Johansson E, Eriksson TL, Höidén-Guthenberg I, Tolmachev V, Nilsson FY, Ståhl S. Friedman M, et al. Among authors: nilsson fy. J Mol Biol. 2008 Mar 7;376(5):1388-402. doi: 10.1016/j.jmb.2007.12.060. Epub 2008 Jan 4. J Mol Biol. 2008. PMID: 18207161

9

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S. Friedman M, et al. Among authors: nilsson fy. Protein Eng Des Sel. 2007 Apr;20(4):189-99. doi: 10.1093/protein/gzm011. Epub 2007 Apr 23. Protein Eng Des Sel. 2007. PMID: 17452435

10

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

Mume E, Orlova A, Larsson B, Nilsson AS, Nilsson FY, Sjöberg S, Tolmachev V. Mume E, et al. Among authors: nilsson fy, nilsson as. Bioconjug Chem. 2005 Nov-Dec;16(6):1547-55. doi: 10.1021/bc050056o. Bioconjug Chem. 2005. PMID: 16287254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters